Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Gubra – Presentation of Q3 2024

Av Claus ThestrupCEO, Sweden
2024-11-07 12:00
Gubra

Meet and ask questions to Gubra’s management – CEO Henrik Blou and CFO Kristian Borbos on 7 November at 12.00 PM when they present the Q3 report 2024.

Focus will be on Q3 report and the underlying growth in the CRO business area. Besides that, we expect an update on potential triggers in the D&P pipeline.

Gubra, founded in 2008 in Denmark, is specialized in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases. Gubra’s activities are focused on the early stages of drug development and are organized in two business areas - CRO Services and Discovery & Partnerships (D&P). The two business areas are highly synergistic and create a unique entity capable of generating a steady cash flow from the CRO business while at the same time enjoying biotechnology upside in the form of potential development milestone payments and potential royalties from the D&P business. Gubra has approx. 200 employees and had annual revenue of above DKK 200 million in 2023. See www.gubra.dk for more information. Gubra is listed on Nasdaq Copenhagen mid Cap, with ticker code: GUBRA.

Disclaimer: HC Andersen Capital receives payment from Gubra for a Digital IR/Corporate Visibility agreement./Claus Thestrup 10 October 2024 at 13.42.

Analytikerintervju: Björn Borg, Metacon & NIBE
2025-05-20 13:28 Björn Borg
Cinclus Pharma, Audiocast, Q1'25
2025-05-20 10:00 Cinclus Pharma
Lagercrantz Group, Audiocast with teleconference, Q4'24/25
2025-05-20 10:00 Lagercrantz Group
Relais as an Investment | Investor Day May, 19, 2025
2025-05-19 15:00 Relais Group
Endomines as an Investment | Investor Day May 19, 2025
2025-05-19 15:00 Endomines Finland
Titta på alla videos
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Our team
  • Inderes som en investering
  • Tjänster för börsbolag
Our platform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet

Sekretessinställningar

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.